← Back to Clinical Trials
Recruiting NCT06449742

NCT06449742 A Prospective Observational Study of Artificial Intelligence Morphometric Evaluation of Vertebral Fractures

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06449742
Status Recruiting
Phase
Sponsor IRCCS San Raffaele
Condition Vertebral Fracture
Study Type OBSERVATIONAL
Enrollment 250 participants
Start Date 2025-03-01
Primary Completion 2026-03-30

Eligibility & Interventions

Sex Male only
Min Age 50 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
AI software and automatic 3D reconstruction

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 250 participants in total. It began in 2025-03-01 with a primary completion date of 2026-03-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The study will be conducted as a monocentric observational prospective study design wants to evaluate the prevalence of vertebral fractures in the cohort of patients that perform a chest-abdomen CT for medical indication other than osteometabolic pathologies.

Eligibility Criteria

Inclusion Criteria: 1. Male subjects 2. Age ≥ 50 years 3. Clinical and medical history data available at abdomen-chest CT evaluation 4. Signature of informed consent to the study Exclusion Criteria: 1. Hospitalized patients 2. Patients known to have osteo-metabolic diseases. 3. with primary and/or acquired immunodeficiency states, and/or severe impairment of general clinical condition (e.g. metastatic neoplasms; immunosuppressive therapies; worsening/reacute/compensated chronic diseases; moderate-severe renal failure) 4. Patients unable to understand and sign the Informed Consent.

Contact & Investigator

Central Contact

Luigi Di Filippo, MD

✉ difilippo.luigi@hsr.it

📞 0226435062

Principal Investigator

Andrea Giustina, MD

PRINCIPAL INVESTIGATOR

IRCCS Ospedale San Raffaele and Vita-Salute San Raffaele University

Frequently Asked Questions

Who can join the NCT06449742 clinical trial?

This trial is open to male participants only, aged 50 Years or older, studying Vertebral Fracture. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06449742 currently recruiting?

Yes, NCT06449742 is actively recruiting participants. Contact the research team at difilippo.luigi@hsr.it for enrollment information.

Where is the NCT06449742 trial being conducted?

This trial is being conducted at Milan, Italy.

Who is sponsoring the NCT06449742 clinical trial?

NCT06449742 is sponsored by IRCCS San Raffaele. The principal investigator is Andrea Giustina, MD at IRCCS Ospedale San Raffaele and Vita-Salute San Raffaele University. The trial plans to enroll 250 participants.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology